Skip to main content
. Author manuscript; available in PMC: 2009 Nov 21.
Published in final edited form as: N Engl J Med. 2008 Nov 20;359(21):2208–2219. doi: 10.1056/NEJMoa0804742

Table 4.

Reclassification of Risk According to the Genotype Score for Subjects in Whom Diabetes Developed and for Those in Whom Diabetes Did Not Develop*

Model without Genotype Score Model with Genotype Score
0 to <2% Risk 2 to <8% Risk ≥8% Risk Total at Risk
number (percent)
Model 1: adjusted for sex
Subjects in whom diabetes developed
 0 to <2% risk 0 0 0 0
 2 to <8% risk 1 (0.4) 242 (94.9) 12 (4.7) 255
 ≥8% risk 0 0 0 0
 Total no. 1 242 12 255
Subjects in whom diabetes did not develop
 0 to <2% risk 0 0 0 0
 2 to <8% risk 65 (1.1) 5731 (97.6) 79 (1.3) 5875
 ≥8% risk 0 0 0 0
 Total no. 65 5731 79 5875
Net reclassification improvement — % 4.1
P value 0.004
Model 2: adjusted for sex and self-reported family history
Subjects in whom diabetes developed
 0 to <2% risk 0 0 0 0
 2 to <8% risk 2 (0.9) 202 (94.8) 9 (4.2) 213
 ≥8% risk 0 17 (40.5) 25 (59.5) 42
 Total no. 2 219 34 255
Subjects in whom diabetes did not develop
 0 to <2% risk 0 0 0 0
 2 to <8% risk 252 (4.6) 5102 (93.8) 87 (1.6) 5441
 ≥8% risk 0 218 (50.2) 216 (49.8) 434
 Total no. 252 5320 303 5875
Net reclassification improvement — % 2.60
P value 0.22
Model 3: adjusted for simple clinical risk factors
Subjects in whom diabetes developed
 0 to <2% risk 20 (83.3) 4 (16.7) 0 24
 2 to <8% risk 4 (7.4) 45 (83.3) 5 (9.2) 54
 ≥8% risk 0 2 (1.1) 175 (98.9) 177
 Total no. 24 51 180 255
Subjects in whom diabetes did not develop
 0 to <2% risk 3924 (97.5) 101 (2.5) 0 4025
 2 to <8% risk 156 (12.2) 1063 (83.4) 56 (4.4) 1275
 ≥8% risk 0 57 (9.9) 518 (90.1) 575
 Total no. 4080 1221 574 5875
Net reclassification improvement — % 2.13
P value 0.17
*

Net reclassification improvement for 255 cases of diabetes among 6130 person-examinations was based on pooled logistic-regression models with generalized estimating equations including or not including the genotype score. Net reclassification improvement is better if more people in whom diabetes develops are reclassified as being at higher risk when the genotype score is added to the model and more people who remain free of diabetes are classified as being at lower risk when the genetic score is added. The net reclassification improvement is worse when there is erroneous reclassification — for example, if many people in whom diabetes develops are classified as being at lower risk when the genetic score is added to the model. The number and proportion of people who were not reclassified by the genotype score are indicated by the bold font.